Anthropic (@AnthropicAI): Many drugs work by binding to a specific target in the body and blocking or changing what it does. An important first step in the drug development process is designing a molecule that can bind tightly
Demonstrates AI's capability for de novo protein design and drug discovery acceleration.
AI Summary
Anthropic's Claude AI autonomously designed novel protein binders against 14 of 15 targets, achieving a 22-35% success rate that outperforms the typical 10-15% .
Excerpt
Many drugs work by binding to a specific target in the body and blocking or changing what it does. An important first step in the drug development process is designing a molecule that can bind tightly to its target. Traditionally, that's meant weeks or months of expert work per https://t.co/CGCNTNaKBq
